Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATeGe in Liver Transplant with Renal Dysfunction
NCT01453218Phase 3Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Oct 2011
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in Liver transplant rejection, sponsored by Vall d'Hebron University Hospital. Started Oct 2011; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01453218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453218.